Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (8)

2021

  1. Obestatin signalling counteracts glucocorticoid-induced skeletal muscle atrophy via NEDD4/KLF15 axis

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 2, pp. 493-505

2018

  1. Erratum to: Obestatin controls skeletal muscle fiber-type determination (Scientific Reports, (2017), 7, 1, (2137), 10.1038/s41598-017-02337-4)

    Scientific Reports

  2. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 9, Núm. 6, pp. 1063-1078

2017

  1. Obestatin controls skeletal muscle fiber-type determination

    Scientific Reports, Vol. 7, Núm. 1

  2. Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid-induced muscle cell atrophy

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 8, Núm. 6, pp. 974-990

2016

  1. β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 3, pp. 617-635

2001

  1. Leptin, reproduction and sex steroids

    Pituitary, Vol. 4, Núm. 1-2, pp. 93-99

1998

  1. PMA inhibits both spontaneous and glucocorticoid-mediated leptin secretion by human omental adipose tissue explants in vitro

    Biochemical and Biophysical Research Communications, Vol. 252, Núm. 2, pp. 345-347